Sectors

The behavioural health assistance platform will get a public listing through the deal, which follows $110m from investors including SoftBank.

Former senior sales director Darren Winter has joined Frontier IP to support its portfolio companies with fundraising.

Illumina Ventures and AV8 Ventures returned for a series A round that will push the startup's liquid biopsy technology towards the clinical trial stage.

Lundbeck and Novo were among the participants in the immuno-oncology drug developer's series B round having backed its series A four years ago.

The GV-backed market intelligence platform developer has pushed its total funding past $150m in a series E round led by WestCap Group.

Tencent led an $83.9m round for the insurance technology developer, which counts Axel Springer and ProSiebenSat.1 among its earlier investors.

The Minth Group, Zoll Medical and Abiomed-backed medical device developer has raised at least $217m in total after closing additional series D funding.

The eye disease device developer has raised series B funding to advance research originating from University of Colorado's s Sue Anschutz-Rodgers Eye Center.

Batton, ExaWizards and Lightblue Technology are all joining the incubator and accelerator jointly run by Toho Gas and Persol’s Eiicon subsidiary.

Pfizer's Breakthrough Growth Initiative has backed the PureTech microbiome spinoff, which will use the cash to finance phase 2 tests of its lead IBD drug candidate.

The book publisher and nursing care service group’s Gakken Innovation-Tech Fund plans to invest about $29m over the next five years, targeting edtech and healthtech.